Gene vaccination with naked plasmid DNA: Mechanism of CTL priming

Journal of Experimental Medicine

Volumn 184, Issue 4, 1996, Pages 1555-1560

  Corr, Maripat ^a   Lee, Delphine J ^a   Carson, Dennis A ^a   Tighe, Helen ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

H2 ANTIGEN; PLASMID DNA; VIRUS NUCLEOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; BONE MARROW; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; INFLUENZA VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOMATIC CELL; VACCINATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; BONE MARROW; FEMALE; HISTOCOMPATIBILITY ANTIGENS; INJECTIONS, INTRAMUSCULAR; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NUCLEOPROTEINS; PLASMIDS; RADIATION CHIMERA; RNA-BINDING PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION; VACCINES, DNA; VIRAL CORE PROTEINS; VIRAL VACCINES;

EID: 0029956512     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.4.1555     Document Type: Article

References (41)

1. Raz, E., D.A. Carson, S.E. Parker, T.B. Parr, A.M. Abai, G. Aichinger, S.H. Gromkowski, M. Singh, D. Lew, M.A. Yankauckas et al. 1994. Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Natl. Acad. Sci. USA. 91:9519-9523.
2. Fynan, E.F., R.G. Webster, D.H. Fuller, J.R. Haynes, J.C. Santoro, and H.L. Robinson. 1993. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. USA. 90:11478-11482.
3. Ulmer, J.B., J.J. Donnelly, S.E. Parker, G.H. Rhodes, P.L. Feigner, V.J. Dwarki, S.H. Gromkowski, R.R. Deck, C.M. DeWitt, A. Friedman et al. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science (Wash. DC). 259:1745-1749.
4. Manickan, E., R.J. Rouse, Z. Yu, W.S. Wire, and B.T. Rouse. 1995. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes. J. Immunol. 155:259-265.
5. Xiang, Z., and H.C. Ertl. 1995. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity. 2:129-135.
6. Whalen, R.G., C. Leclerc, E. Deriaud, R. Schirmbeck, J. Reimann, and H.L. Davis. 1995. DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response. Ann. NY Acad. Sci. 772: 64-76.
7. Davis, H.L., R. Schirmbeck, J. Reimann, and R.G. Whalen. 1995. DNA-mediated immunization in mice induces a potent MHC class I-restricted cytotoxic T lymphocyte response to the hepatitis B envelope protein. Hum. Gene Ther. 6:1447-1456.
8. Raz, E., H. Tighe, Y. Sato, M. Corr, J.A. Dudler, M. Roman, S.L. Swain, H.L. Spiegelberg, and D.A. Carson. 1996. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc. Natl. Acad. Sci. USA. 93:5141-5145.
9. Watanabe, A., E. Raz, H. Kohsaka, H. Tighe, S.M. Baird, T.J. Kipps, and D.A. Carson. 1993. Induction of antibodies to a kappa V region by gene immunization. J. Immunol. 151: 2871-2876.
10. Pardoll, D.M., and A.M. Beckerleg. 1995. Exposing the immunology of naked DNA vaccines. Immunity. 3:165-169.
11. Neefjes, J.J., and H.L. Ploegh. 1992. Intracellular transport of MHC class II molecules. Immunol. Today. 13:179-184.
12. Nickloff, B.M. 1993. Dermal Immune System. CRC Press, Inc., Boca Raton, Florida.
13. Hohlfeld, R., and A.G., Engel. 1994. The immunobiology of muscle. Immunology. Today. 15:269-274.
14. Austyn, J.M., D.F. Hankins, C.P. Larsen, P.J. Morris, A.S. Rao, and J.A. Roake. 1994. Isolation and characterization of dendritic cells from mouse heart and kidney. J. Immunol. 152: 2401-2410.
15. Wolff, J.A., R.W. Malone, P. Williams, W. Chong, G. Acsadi, A. Jani, and P.L. Felgner. 1990. Direct gene transfer into mouse muscle in vivo. Science (Wash. DC). 247:1465-1468.
16. Lamb, J.R., B.J. Skidmore, N. Green, J.M. Chiller, and M. Feldmann. 1983. Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin. J. Exp. Med. 157:1434-1447.
17. Jenkins, M.K., and R.H. Schwartz. 1987. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165:302-319.
18. Quill, H., and R.H. Schwartz. 1987. Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: specific induction of a long-lived state of proliferative nonresponsiveness. J. Immunol. 138:3704-3412.
19. Mueller, D.L., M.K. Jenkins, and R.H. Schwartz. 1989. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7: 445-480.
20. Kundig, T.M., M.F. Bachmann, C. DiPaolo, J.J. Simard, M. Battegay, H. Lother, A. Gessner, K. Kuhlcke, P.S. Ohashi, H. Hengartner, and R.M. Zinkernagel. 1995. Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science (Wash. DC). 268:1343-1347.
21. Schirmbeck, R., K. Melber, and J. Reimann. 1995. Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I-restricted epitope presentation. Eur. J. Immunol. 25: 1063-1070.
22. Bohm, W., R. Schirmbeck, A. Elbe, K. Melber, D. Diminky, G. Kraal, N. van Rooijen, Y. Barenholz, and J. Reimann. 1995. Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo. J. Immunol. 155:3313-3321.
23. Martinez-Kinader, B., G.B. Lipford, H. Wagner, and K. Heeg. 1995. Sensitization of MHC class I-restricted T cells to exogenous proteins: evidence for an alternative class I-restricted antigen presentation pathway. Immunology. 86:287-295.
24. Kovacsovics-Bankowski, M., and K.L. Rock. 1995. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science (Wash. DC). 267:243-246.
25. Reis e Sousa, C., and R.N. Germain. 1995. Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J. Exp. Med. 182:841-851.
26. Pfeifer, J.D., M.J. Wick, R.L. Roberts, K. Findlay, S.J. Normark, and C.V. Harding. 1993. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature (Lond.). 361:359-3562.
27. Harding, C.V., R. Song, J. Griffin, J. France, M.J. Wick, J.D. Pfeifer, and H.J. Geuze. 1995. Processing of bacterial antigens for presentation to class I and II MHC-restricted T lymphocytes. Infect. Agents Dis. 4:1-12.
28. Staerz, U.D., H. Karasuyama, and A.M. Garner. 1987. Cytotoxic T lymphocytes against a soluble protein. Nature (Lond.). 329:449-451.
29. Carbone, F.R., and M.J. Bevan. 1990. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J. Exp. Med. 171:377-387.
30. Rock, K.L. 1996. A new foreign policy: MHC class I molecules monitor the outside world. Immunology Today. 17: 131-137.
31. Bevan, M.J. 1976. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143: 1283-1288.
32. Huang, A.Y., P. Golumbek, M. Ahmadzadeh, E. Jaffee, D. Pardoll, and H. Levitsky. 1994. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science (Wash. DC). 264:961-965.
33. Falk, K., O. Rotzschke, S. Stevanovic, G. Jung, and H.G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature (Lond.). 351:290-296.
34. Fink, P.J., and M.J. Bevan. 1978. H-2 antigens of the thymus determine lymphocyte specificity. J. Exp. Med. 148:766-775.
35. Dick, L.R., C. Aldrich, S.C. Jameson, C.R. Moomaw, B.C. Pramanik, C.K. Doyle, G.N. DeMartino, M.J. Bevan, J.M. Forman, and C.A. Slaughter. 1994. Proteolytic processing of ovalbumin and beta-galactosidase by the proteasome to a yield antigenic peptides. J. Immunol. 15:23884-23894.
36. Monaco, J.J., S. Cho, and M. Attaya. 1990. Transport protein genes in the murine MHC: possible implications for antigen processing. Science (Wash. DC). 250:1723-1726.
37. Yewdell, J.W., and J.R. Bennink. 1992. Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes. Adv. Immunol. 52:11-23.
38. Townsend, A., and J. Trowsdale. 1993. The transporters associated with antigen presentation. Semin. Cell Biol. 4:53-61.
39. Suto, R., and P.K. Srivastava. 1995. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science (Wash. DC). 269:1585-1588.
40. Harding, C.V., and R. Song. 1994. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J. Immunol. 153:4925-4933.
41. Huang, A.Y., A.T. Bruce, D.M. Pardoll, and H.I. Levitsky. 1996. In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter. Immunity. 4:349-355.